Perindopril

Perindopril is an ACE inhibitor prodrug used to treat hypertension, mild to moderate congestive heart failure, and to reduce cardiovascular risk in patients with hypertension or post-myocardial infarction. Perindopril is a nonsulfhydryl prodrug that belongs to the angiotensin-converting enzyme (ACE) inhibitor class of medications.

Chemical structure of Perindopril
Mechanism
Curator reviewed
Primary indication
For the treatment of mild to moderate essential hypertension, mild to moderate congestive heart failure, and to reduce the cardiovascular risk of individuals with hypertension or post-myocardial infarction and stable coronary disease.Curator reviewed · 10 structured indications
Formula / weight
C19H32N2O5 · 368.4678 g/mol (avg)
First approval
Canada, 2002 · United States, 1993
Brand names
  • Aceon
  • Coversyl
  • Prestalia
  • Viacoram

Resolves to

Structure
InChIKeyIPVQLZZIHOAWMC-QXKUPLGCSA-NSMILES[H][C@]12C[C@H](N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@@]1([H])CCCC2)C(O)=O

What you can answer from here — as of September 13, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
2TransportersSubstrate / inhibitor direction, not just membership
Listed above
1,323Drug interactionsStructured to mechanism, not free text
Sign in
74Clinical trialsPhase, status and sponsor resolved per trial
Sign in
10Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
4ContraindicationsEach with its own population and attribute set
Sign in
1,612Marketed productsAcross 11 countries and 90 labellers
Sign in
13ATC codesIncluding every combination product, plus 22 drug categories
Sign in
18+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Perindopril, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account